高血圧患者および無高血圧患者の動脈硬化,血液動力学的パラメータおよび大動脈構造の生理学的ネットワーク分析
1Universidad Científica del Sur, Lima, Perú.
まとめ
高血圧は血管ネットワークを変化させ,動脈の硬さと接続性を高めます. 静止血圧は,高血圧患者の生理学的ネットワークにおいて優位な役割を果たします.
科学分野:
- 心血管生理学 心血管の生理学
- ネットワーク科学 ネットワーク科学
- メディカルイマージング (医学イメージング)
背景:
- 高血圧は,血管の改造と血液動力学的変化と関連しています.
- これらのプロセスの統合された相互作用は完全に理解されていません.
- 動脈の硬化と大動脈の構造は,血管の健康の重要な要素です.
研究 の 目的:
- 動脈の硬さ,血液動力学,大動脈構造を統合した生理学的ネットワーク構造を分析する.
- これらのネットワークを高血圧対非高血圧の個体で比較する.
- 高血圧に関連した血管ネットワークのトポロジカルな差異を特定する.
主な方法:
- 801人の患者の二次データセット分析.
- 動脈の硬さは,心臓-足首血管指数 (CAVI-L/R) によって評価される.
- コンピュータトモグラフィーで測定された大動脈直径.
- EBIC-GLASSOを使用して構築された生理学的ネットワーク.
- ネットワークの中央性とグローバルメトリックを計算した.
- 比較のために使用されたネットワーク比較テスト (NCT).
主要な成果:
- 高血圧患者は,異なるネットワークトポロジーを示した.
- 高血圧群におけるCAVI-L,BMI,および静脈動脈血圧の度合いと強さの上昇.
- 特定の大動脈のセグメント (ヴァルサルヴァの鼻腔,大動脈のアーチ,近親下下大動脈) の間隔値が高くなります.
- 高血圧ネットワークは,より高い密度と,より低い機能的差異を示した.
- ダイアストリック血圧は,高血圧グループでは,統計的に有意なグローバルネットワークの強さを示した.
結論:
- 高血圧は,血管組織の全体的な変化と関連しています.
- 動脈の硬化とネットワーク接続性の増加は高血圧の特徴です.
- ディアストリック血圧は,高血圧の生理学的ネットワークにおいて,主たる機能的役割を演じている.
関連する概念動画
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
630
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
630
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
489
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
489
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
527
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
527
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
478
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
478
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
643
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
643
Protein Networks
4.6K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.6K


